The dynamics of procalcitonin in COVID-19 patients admitted to Intensive care unit - a multi-centre cohort study in the South West of England, UK

J Infect. 2021 Jun;82(6):e24-e26. doi: 10.1016/j.jinf.2021.03.011. Epub 2021 Mar 18.

Authors

Philip Williams¹, Chris McWilliams², Kamran Soomro³, Irasha Harding⁴, Stefan Gurney⁵, Matt Thomas⁶, Maha Albur⁶, O Martin Williams⁴

Affiliations

¹ University of Bristol UK; PHE National Infection Service UK. Electronic address: Philip.williams2@uhbw.nhs.uk.
² University of Bristol UK; University Hospitals Bristol and Weston NHS Trust UK.
³ University Hospitals Bristol and Weston NHS Trust UK; University of the West of England UK.
⁴ PHE National Infection Service UK.
⁵ University Hospitals Bristol and Weston NHS Trust UK.
⁶ North Bristol NHS Trust UK.

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Antifungal Agents
COVID-19*
Cohort Studies
England / epidemiology
Hospitals
Humans
Intensive Care Units
Procalcitonin*
SARS-CoV-2
Scotland
United Kingdom

Substances

Anti-Bacterial Agents
Antifungal Agents
Procalcitonin

Grants and funding

MR/T005408/1/MRC_/Medical Research Council/United Kingdom